Log in to save to my catalogue

Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/m...

Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6610044

Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice

About this item

Full title

Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice

Publisher

Greece: Spandidos Publications UK Ltd

Journal title

Oncology reports, 2019-08, Vol.42 (2), p.479-494

Language

English

Formats

Publication information

Publisher

Greece: Spandidos Publications UK Ltd

More information

Scope and Contents

Contents

Skeletal muscle wasting is a feature of cancer cachexia that increases patient morbidity and mortality. Matrine, the main bioactive component of Sophora flavescens, has been approved for the prevention and therapy of cancer cachexia in China. However, to the best of our knowledge, its mechanism in improving muscle wasting remains unknown. The prese...

Alternative Titles

Full title

Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6610044

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6610044

Other Identifiers

ISSN

1021-335X

E-ISSN

1791-2431

DOI

10.3892/or.2019.7205

How to access this item